We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Report of the findings of the ACMD's inquiry on children of problem drug users in the UK.
Advice on preventing drug misuse among vulnerable groups of people, with a focus on understanding factors that contribute to vulnerability.
Review of the evidence on the use and harms of xylazine, medetomidine and detomidine.
Call for evidence from the Advisory Council on the Misuse of Drugs on the prevalence and drivers of powder cocaine use by young people and adults.
An assessment of the impact of rescheduling CBPMs to Schedule 2 under the Misuse of Drugs Regulations 2001 (MDR) and recommendations to mitigate the issues identified.
Government response to the report by the Advisory Council on the Misuse of Drugs on acyl piperazine opioids, including 2-methyl-AP-237.
The Advisory Council on the Misuse of Drugs has undertaken a review of the availability and implementation of naloxone in the UK.
The Advisory Council on the Misuse of Drugs call for evidence, collecting written evidence to better understand internet-facilitated drug markets (IFDMs).
The chair of the Advisory Council on the Misuse of Drugs (ACMD) writes to Theresa May about nitrous oxide abuse.
The Home Secretary has accepted the ACMD’s recommendation to reclassify methylamphetamine to a Class A Drug. Methylamphetamine (commonly referred…
This report provides an updated harms assessment to the ACMD's previous reports on synthetic cannabinoid receptor agonists.
'Ketamine: a review of use and harm' provides advice from the Advisory Council on the Misuse of Drugs to the Home Secretary.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
The chair of the Advisory Council on the Misuse of Drugs writes to Karen Bradley about Pregabalin and Gabapentin.
Letter to the Home Office setting out the ACMD’s review of alkyl nitrites (poppers).
The ACMD has recommended that cannabis-derived medicinal products should be placed in Schedule 2 of the Misuse of Drugs Regulations 2001.
ACMD report providing advice to the government on the factors that make the homeless population vulnerable to substance misuse harms and how these can reduced.
The Advisory Council on the Misuse of Drugs (ACMD) seeks to gather insight into current government-led drug prevention policies and landscape across the UK.
The (ACMD) Recovery Committee’s briefing paper on the prevention of drug and alcohol dependence.
Independent report by the Advisory Council on the Misuse of Drugs (ACMD) investigates the risk factors to substance use-related problems and harms.
ACMD work programme 2024 letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs (ACMD).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).